Novo Nordisk (NYSE:NVO) has outperformed the market over the past 5 years by 8.62% on an annualized basis producing an average annual return of 21.07%. Currently, Novo Nordisk has a market capitalization of $367.51 billion.
Buying $100 In NVO: If ...